Terms: = Uterine cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Clinical Outcome
62 results:
1. outcome prediction for symptomatic patients with fibroids who underwent uterine artery embolization.
Wu Q; Motaghi M; Tang H; Hazhirkarzar B; Shaghaghi M; Ghadimi M; Baghdadi A; Rezvani R; Mohseni A; Borhani A; Madani SP; Afyouni S; Zandieh G; Kamel IR
Clin Imaging; 2024 Jan; 105():110028. PubMed ID: 38039750
[TBL] [Abstract] [Full Text] [Related]
2. Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK.
Evans I; Reisel D; Jones A; Bajrami A; Nijjar S; Solangon SA; Arora R; Redl E; Schreiberhuber L; Ishaq-Parveen I; Rothärmel J; Herzog C; Jurkovic D; Widschwendter M
Lancet Oncol; 2023 Dec; 24(12):1375-1386. PubMed ID: 37944542
[TBL] [Abstract] [Full Text] [Related]
3. The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study.
Song S; Han D; Zhang N; Mao Z; Guo X; Cheng G
Radiat Oncol; 2023 Mar; 18(1):46. PubMed ID: 36879287
[TBL] [Abstract] [Full Text] [Related]
4. Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
Chopra S; Mulani J; Mittal P; Singh M; Shinde A; Gurram L; Scaria L; Aravindakshan D; Kohle S; Rane P; Ghadi Y; Rath S; Ghosh J; Gulia S; Gupta S; Kinhikar R; Laskar S; Agarwal JP
Brachytherapy; 2023; 22(2):125-131. PubMed ID: 36585283
[TBL] [Abstract] [Full Text] [Related]
5. clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer.
Rogowski P; Rottler M; Walter F; Saicic S; Niyazi M; Well J; Nierer L; Trillsch F; Burges A; Mahner S; Belka C; Corradini S
Gynecol Oncol; 2022 Sep; 166(3):576-581. PubMed ID: 35764443
[TBL] [Abstract] [Full Text] [Related]
6. clinical outcome of pulmonary lymphangitic carcinomatosis in gynecologic malignancy: A single-institution experience.
Kim MS; Jeong SY; Lee YY; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
Taiwan J Obstet Gynecol; 2022 Mar; 61(2):333-338. PubMed ID: 35361397
[TBL] [Abstract] [Full Text] [Related]
7. "Long-term outcome in endometrial cancer patients after robot-assisted laparoscopic surgery with sentinel lymph node mapping".
Jebens Nordskar N; Hagen B; V Vesterfjell E; Salvesen Ø; Aune G
Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():77-82. PubMed ID: 35151960
[TBL] [Abstract] [Full Text] [Related]
8. The Impact of Histological Subtype on Survival outcome of Patients with Stage IIB-IVA Cervical cancer Who Received Definitive Radiotherapy.
Miyahara S; Tsuji K; Shimada M; Shibuya Y; Shigeta S; Nagai T; Umezawa R; Tokunaga H; Jingu K; Yaegashi N
Tohoku J Exp Med; 2021 Dec; 255(4):303-313. PubMed ID: 34911878
[TBL] [Abstract] [Full Text] [Related]
9. clinical results of image-guided interstitial brachytherapy with or without external beam radiotherapy for postsurgical vaginal recurrence of cervical and endometrial cancers.
Kanemoto A; Sugita T; Ayukawa F; Takahashi K; Horiuchi A; Haino K; Kikuchi A
Jpn J Radiol; 2022 Jun; 40(6):639-644. PubMed ID: 34851502
[TBL] [Abstract] [Full Text] [Related]
10. Quality of life and long-term clinical outcome following robot-assisted radical trachelectomy.
Ekdahl L; Crusensvärd M; Reynisson P; Lönnerfors C; Persson J
Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():234-240. PubMed ID: 34837852
[TBL] [Abstract] [Full Text] [Related]
11. Endovascular embolization as a treatment for symptomatic adenomyosis - results of preliminary study.
Pyra K; Szmygin M; Szmygin H; Bèrczi V; Kidzinski R; Jargiello T; Paszkowski T; Wozniak S
Ginekol Pol; 2022; 93(4):273-277. PubMed ID: 34263918
[TBL] [Abstract] [Full Text] [Related]
12. Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
Reijnen C; Küsters-Vandevelde HVN; Ligtenberg MJL; Bulten J; Oosterwegel M; Snijders MPLM; Sweegers S; de Hullu JA; Vos MC; van der Wurff AAM; van Altena AM; Eijkelenboom A; Pijnenborg JMA
Int J Cancer; 2020 Jul; 147(2):478-489. PubMed ID: 32022266
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
León-Castillo A; Gilvazquez E; Nout R; Smit VT; McAlpine JN; McConechy M; Kommoss S; Brucker SY; Carlson JW; Epstein E; Rau TT; Soslow RA; Ganesan R; Matias-Guiu X; Oliva E; Harrison BT; Church DN; Gilks CB; Bosse T
J Pathol; 2020 Mar; 250(3):312-322. PubMed ID: 31829447
[TBL] [Abstract] [Full Text] [Related]
14. Association Between Radiation Tolerance of Lymphocytes and clinical outcomes in Cervical cancer.
Lee S; Cho O; Chun M; Chang SJ; Kong TW; Lee EJ; Lee Y
In Vivo; 2019; 33(6):2191-2198. PubMed ID: 31662555
[TBL] [Abstract] [Full Text] [Related]
15. Five-year clinical outcomes of uterine artery embolization for symptomatic leiomyomas: An analysis of risk factors for reintervention.
Yoon JK; Han K; Kim MD; Kim GM; Kwon JH; Won JY; Lee DY
Eur J Radiol; 2018 Dec; 109():83-87. PubMed ID: 30527317
[TBL] [Abstract] [Full Text] [Related]
16. clinical outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy Only.
Smogeli E; Cvancarova M; Wang Y; Davidson B; Kristensen G; Lindemann K
Int J Gynecol Cancer; 2018 Nov; 28(9):1789-1795. PubMed ID: 30365455
[TBL] [Abstract] [Full Text] [Related]
17. uterine fibroid embolization with acrylamido polyvinyl microspheres: prospective 12-month clinical and MRI follow-up study.
Duvnjak S; Ravn P; Green A; Andersen PE
Acta Radiol; 2017 Aug; 58(8):952-958. PubMed ID: 27872351
[TBL] [Abstract] [Full Text] [Related]
18. Differences in outcome for cervical cancer patients treated with or without brachytherapy.
Karlsson J; Dreifaldt AC; Mordhorst LB; Sorbe B
Brachytherapy; 2017; 16(1):133-140. PubMed ID: 27836496
[TBL] [Abstract] [Full Text] [Related]
19. A volumetric analysis of GTV
Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
[TBL] [Abstract] [Full Text] [Related]
20. Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer.
Lee J; Kim TH; Kim GE; Keum KC; Kim YB
J Gynecol Oncol; 2016 Sep; 27(5):e52. PubMed ID: 27329200
[TBL] [Abstract] [Full Text] [Related]
[Next]
